15250-m-cuypers

135 Regret and information satisfaction at one-year follow-up 7 up questionnaires were sent 6 (T2) and 12 months (T3) later. Patients were unaware of assignment to trial arm as the DA was not mentioned as subject of this study. Care providers and researchers were not blinded of trial assignment (29). Intervention In addition to all information provided as part of usual care, patients in the intervention arm were invited by their care provider to access the DA online. The DA included information about all treatments, values clarification exercises (VCEs), and a summary that could be taken to the next consultation. Based on which treatments the patients was eligible for, the DA allowed patients to skip elements about treatments they were not eligible for (30). Randomization of hospitals, N=18 Hospitals randomized to DA counseling, N=9 Hospitals randomized to standard counseling, N=9 Patients signing informed consent: n=273 DAs distributed: n=273 Patients using DA: n=229 Patients signing informed consent: n=111 Patients receiving usual counseling: n=111 After treatment decision-making: Patients receiving questionnaire: n=273 Patients completing questionnaire: n=235 6 months: Patients receiving questionnaire: n=235 Patients completing questionnaire: n=214 12 months: Patients receiving questionnaire: n=214 Patients completing questionnaire: n=208 After treatment decision-making: Patients receiving questionnaire: n=111 Patients completing questionnaire: n=101 6 months: Patients receiving questionnaire: n=101 Patients completing questionnaire: n=94 12 months: Patients receiving questionnaire: n=94 Patients completing questionnaire: n=85 Enrollment of patients Treatment decision-making Figure 1. Flow diagram of patients included in the Prostate Cancer Patient Centered Care (PCPCC) trial